Microfibrillar-associated protein 4 as a predictive biomarker of treatment response in patients with chronic inflammatory diseases initiating biologics: secondary analyses based on the prospective BELIEVE cohort study.
Sofíudóttir BK, Munk HL, Christensen R, Möller S, Overgaard SH, Sorensen GL, Møllegaard KM, Pingel J, Nexøe AB, Glerup H, Guldmann T, Pedersen N, Dahlerup JF, Hvas CL, Andersen KW, Jawhara M, Nielsen OH, Bergenheim FO, Bygum A, Davidsen JR, Sørensen SB, Brodersen JB, Kjeldsen J, Andersen V, Ellingsen T.
Sofíudóttir BK, et al. Among authors: davidsen jr.
Rheumatol Int. 2024 Oct 28. doi: 10.1007/s00296-024-05744-9. Online ahead of print.
Rheumatol Int. 2024.
PMID: 39465398